Medicine & Pharmaceuticals

Latest News Releases

*DISCLAIMER*: Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.

HeadlinesMore>>
Weight Loss Surgery with Dr. Feiz and Associates Can Add Up to 14 Years to Life Expectancy
Weight Loss Surgery with Dr. Feiz and Associates Can Add Up to 14 Years to Life Expectancy
One of the most frequent worries leading bariatric surgeon Michael Feiz, M.D., F.A.C.S. hears when people come to his office seeking weight loss surgery is that they fear they will pass away early and have less time to...More >>
One of the most frequent worries leading bariatric surgeon Michael Feiz, M.D., F.A.C.S. hears when people come to his office seeking weight loss surgery is that they fear they will pass away early and have less time to...More >>
House Calls Save Patients Money
House Calls Save Patients Money
For those who aren't comfortable with the crowds and impersonal, rushed medical care found at the average walk in clinic in Los Angeles, Dr. Michael Farzam and his team at House Call Doctor Los Angeles offer a welcome...More >>
For those who aren't comfortable with the crowds and impersonal, rushed medical care found at the average walk in clinic in Los Angeles, Dr. Michael Farzam and his team at House Call Doctor Los Angeles offer a welcome...More >>
How to Get a Body Like Your Favorite Superstars
How to Get a Body Like Your Favorite Superstars
Women who are having trouble attaining their superstar dream body through diet and exercise alone are increasingly turning to plastic surgery to get the results they want. Beverly Hills Physicians is a Los Angeles medical...More >>
Women who are having trouble attaining their superstar dream body through diet and exercise alone are increasingly turning to plastic surgery to get the results they want. Beverly Hills Physicians is a Los Angeles medical...More >>
Institute for Supply Management, Michigan State University to recognize companies with excellent supply management practices
Institute for Supply Management, Michigan State University to recognize companies with excellent supply management practices
There is still time to share your procurement and supply chain organization's success. The 10th Annual Institute for Supply Management® – Michigan State University Awards for Excellence in Supply Management is open for...More >>
There is still time to share your procurement and supply chain organization's success. The 10th Annual Institute for Supply Management® – Michigan State University Awards for Excellence in Supply Management is open for...More >>
Advanced Photonix to Webcast Fiscal 2015 First Quarter Earnings
Advanced Photonix to Webcast Fiscal 2015 First Quarter Earnings
Advanced Photonix® (NYSE MKT: API) will announce its FY2015 first quarter (ending June 27, 2014) financial results on Monday, August 11, 2014. A press release announcing the financial results will be released after the...More >>
Advanced Photonix® (NYSE MKT: API) will announce its FY2015 first quarter (ending June 27, 2014) financial results on Monday, August 11, 2014. A press release announcing the financial results will be released after the...More >>
AUA Responds to Important New IOM Report on Graduate Medical Education Funding and Governance
AUA Responds to Important New IOM Report on Graduate Medical Education Funding and Governance
The American Urological Association (AUA) today issued a statement in response to the new Institute of Medicine (IOM) July 29 report, "Graduate Medical Education that Meets the Nation's Health Needs." The below...More >>
The American Urological Association (AUA) today issued a statement in response to the new Institute of Medicine (IOM) July 29 report, "Graduate Medical Education that Meets the Nation's Health Needs." The below...More >>
Nuvo Research® announces 2014 second quarter results
Nuvo Research® announces 2014 second quarter results
MISSISSAUGA, ON, July 30, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced its financial and operational...More >>
MISSISSAUGA, ON, July 30, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced its financial and operational...More >>
Unilife Accelerates Investment to Meet Increasing Demand from New and Existing Customers
Unilife Accelerates Investment to Meet Increasing Demand from New and Existing Customers
Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS), a developer and supplier of injectable drug delivery systems, today announced an acceleration of investments in manufacturing capacity, R&D, and...More >>
Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS), a developer and supplier of injectable drug delivery systems, today announced an acceleration of investments in manufacturing capacity, R&D, and...More >>
CryoLife Announces Quarterly Cash Dividend for the Third Quarter 2014
CryoLife Announces Quarterly Cash Dividend for the Third Quarter 2014
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that its Board of Directors has approved a quarterly cash dividend for the third...More >>
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that its Board of Directors has approved a quarterly cash dividend for the third...More >>
DURECT Corporation Invites You to Join its Second Quarter 2014 Earnings Conference Call
DURECT Corporation Invites You to Join its Second Quarter 2014 Earnings Conference Call
In conjunction with DURECT Corporation's (Nasdaq: DRRX) second quarter 2014 financial results press release, you are invited to listen to the conference call that will be broadcast live over the internet on Thursday,...More >>
In conjunction with DURECT Corporation's (Nasdaq: DRRX) second quarter 2014 financial results press release, you are invited to listen to the conference call that will be broadcast live over the internet on Thursday,...More >>
Endo appoints Shane M. Cooke to Board of Directors
Endo appoints Shane M. Cooke to Board of Directors
Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced the appointment of Shane M. Cooke to the company's board of directors. Mr. Cooke, an international business leader with more than 25 years of...More >>
Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced the appointment of Shane M. Cooke to the company's board of directors. Mr. Cooke, an international business leader with more than 25 years of...More >>
Synageva BioPharma™ Reports Second Quarter 2014 Financial Results
Synageva BioPharma™ Reports Second Quarter 2014 Financial Results
Synageva BioPharma Corp. ("Synageva") (NASDAQ: GEVA), a biopharmaceutical company developing therapeutic products for rare disorders, today reported second quarter 2014 financial results, and provided other business updates.More >>
Synageva BioPharma Corp. ("Synageva") (NASDAQ: GEVA), a biopharmaceutical company developing therapeutic products for rare disorders, today reported second quarter 2014 financial results, and provided other business updates.More >>
Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement
Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement
Cepheid (Nasdaq: CPHD) today announced that its group purchasing contract with Premier will end on September 30, 2014. Customers currently purchasing through the Premier GPO will be able to continue their relationship...More >>
Cepheid (Nasdaq: CPHD) today announced that its group purchasing contract with Premier will end on September 30, 2014. Customers currently purchasing through the Premier GPO will be able to continue their relationship...More >>
Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call
Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call
Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it will report financial results and highlights...More >>
Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it will report financial results and highlights...More >>
Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission
Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that the Companies intend to use a U.S. Food and Drug Administration (FDA) rare pediatric disease priority review...More >>
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that the Companies intend to use a U.S. Food and Drug Administration (FDA) rare pediatric disease priority review...More >>
Hologic Announces Third Quarter Fiscal 2014 Operating Results
Hologic Announces Third Quarter Fiscal 2014 Operating Results
Hologic, Inc. (NASDAQ: HOLX) today announced its results for the third fiscal quarter ended June 28, 2014.More >>
Hologic, Inc. (NASDAQ: HOLX) today announced its results for the third fiscal quarter ended June 28, 2014.More >>
AMCP Endorses JCPP "Pharmacists' Patient Care Process"
AMCP Endorses JCPP "Pharmacists' Patient Care Process"
The Board of Directors of the Academy of Managed Care Pharmacy (AMCP) last evening expressed support for the "Pharmacists' Patient Care Process" recently developed by the Joint Commission of Pharmacy Practitioners...More >>
The Board of Directors of the Academy of Managed Care Pharmacy (AMCP) last evening expressed support for the "Pharmacists' Patient Care Process" recently developed by the Joint Commission of Pharmacy Practitioners...More >>
The 29th Annual Great Sports Legends Dinner To Honor Hakeem Olajuwon, Warren Sapp, Pedro Martinez, Mary Lou Retton, Bill Cowher And More
The 29th Annual Great Sports Legends Dinner To Honor Hakeem Olajuwon, Warren Sapp, Pedro Martinez, Mary Lou Retton, Bill Cowher And More
The Buoniconti Fund to Cure Paralysis will present the 29th Annual Great Sports Legends Dinner at the Waldorf Astoria on Monday, September 29, 2014. The annual event, hosted by NFL Hall of Famer Nick Buoniconti and his son...More >>
The Buoniconti Fund to Cure Paralysis will present the 29th Annual Great Sports Legends Dinner at the Waldorf Astoria on Monday, September 29, 2014. The annual event, hosted by NFL Hall of Famer Nick Buoniconti and his son...More >>
White House Responds to The Race to Yes Petition
White House Responds to The Race to Yes Petition
In response to the 106,782 signatures collected through TheRacetoYes.Org petition urging the "FDA to Say Yes to Accelerated Approval for safe, effective therapies for children with Duchenne" muscular dystrophy, the White...More >>
In response to the 106,782 signatures collected through TheRacetoYes.Org petition urging the "FDA to Say Yes to Accelerated Approval for safe, effective therapies for children with Duchenne" muscular dystrophy, the White...More >>
Fifth Annual Kiehl's LifeRide For amfAR Cruises In Style With Harley-Davidson® Authorized Rentals
Fifth Annual Kiehl's LifeRide For amfAR Cruises In Style With Harley-Davidson® Authorized Rentals
Harley-Davidson Authorized Rentals, the world's largest motorcycle rentals provider, is joining with world renowned skincare company Kiehl's Since 1851 as the exclusive motorcycle partner and Gold Sponsor of the...More >>
Harley-Davidson Authorized Rentals, the world's largest motorcycle rentals provider, is joining with world renowned skincare company Kiehl's Since 1851 as the exclusive motorcycle partner and Gold Sponsor of the...More >>
Dr. Craig McAllister and EvergreenHealth are First on West Coast to Offer Outpatient Hip and Knee Replacement Surgery
Dr. Craig McAllister and EvergreenHealth are First on West Coast to Offer Outpatient Hip and Knee Replacement Surgery
Thanks to advances in minimally invasive surgery, pain management, preoperative preparation and rapid rehabilitation methods, patients of Dr. Craig McAllister at EvergreenHealth in Kirkland, Washington, can now receive...More >>
Thanks to advances in minimally invasive surgery, pain management, preoperative preparation and rapid rehabilitation methods, patients of Dr. Craig McAllister at EvergreenHealth in Kirkland, Washington, can now receive...More >>
CareFit E-Portfolio Program Open Enrollment For Homecare Professionals: In Search Of Greatness
CareFit E-Portfolio Program Open Enrollment For Homecare Professionals: In Search Of Greatness
Mike Fallon and Fedor Steer, AKA CareFit, announce their first Open Enrollment in search of the best caregivers in Collier and Lee counties to join their e-portfolio caregiving program.More >>
Mike Fallon and Fedor Steer, AKA CareFit, announce their first Open Enrollment in search of the best caregivers in Collier and Lee counties to join their e-portfolio caregiving program.More >>
Telligen Wins Quality Innovation Network Award for Iowa, Illinois and Colorado
Telligen Wins Quality Innovation Network Award for Iowa, Illinois and Colorado
Telligen, Inc., a leader in population health management solutions, has been awarded the Centers for Medicare & Medicaid Services (CMS) Quality Innovation Network Quality Improvement Organization (QIN-QIO) contract for...More >>
Telligen, Inc., a leader in population health management solutions, has been awarded the Centers for Medicare & Medicaid Services (CMS) Quality Innovation Network Quality Improvement Organization (QIN-QIO) contract for...More >>
PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M
PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M
PuraMed BioScience®, Inc., (OTCPink:PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that the company is rebranding the LipiGesic® M name along with...More >>
PuraMed BioScience®, Inc., (OTCPink:PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that the company is rebranding the LipiGesic® M name along with...More >>
Great American Group Analysts See Continued Changes in Healthcare
Great American Group Analysts See Continued Changes in Healthcare
Analysts with Great American Group, Inc. (OTCBB: GAMR) report that as the healthcare industry continues to undergo unprecedented changes, including reforms of the Affordable Care Act ("ACA"), wider consumer choice, public...More >>
Analysts with Great American Group, Inc. (OTCBB: GAMR) report that as the healthcare industry continues to undergo unprecedented changes, including reforms of the Affordable Care Act ("ACA"), wider consumer choice, public...More >>
Indoor and Outdoor Sun Tanning or Sun Burns Directly Linked to Deadly Melanoma Skin Cancer
Indoor and Outdoor Sun Tanning or Sun Burns Directly Linked to Deadly Melanoma Skin Cancer
Today the US Surgeon General issued the most stern warning to date for indoor and outdoor sun tanning or sun burns stating they can lead directly to deadly melanoma skin cancer. In his statement Surgeon, General Boris...More >>
Today the US Surgeon General issued the most stern warning to date for indoor and outdoor sun tanning or sun burns stating they can lead directly to deadly melanoma skin cancer. In his statement Surgeon, General Boris...More >>
Hematology Analyzers & Reagents Market - Forecasts to 2019
Hematology Analyzers & Reagents Market - Forecasts to 2019
Research and Markets has announced the addition of the "Hematology Analyzers & Reagents Market - Forecasts to 2019" report to their offering.More >>
Research and Markets has announced the addition of the "Hematology Analyzers & Reagents Market - Forecasts to 2019" report to their offering.More >>
Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake
Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake
Decision Resources Group finds that the majority of surveyed pharmacy and medical directors in the United States believe that the key drivers of biosimilar market penetration will be the level of savings achievable by...More >>
Decision Resources Group finds that the majority of surveyed pharmacy and medical directors in the United States believe that the key drivers of biosimilar market penetration will be the level of savings achievable by...More >>
El Camino Hospital Utilizes Cutting-Edge Leaf Patient Monitor System to Help Reduce Risk of Pressure Ulcers
El Camino Hospital Utilizes Cutting-Edge Leaf Patient Monitor System to Help Reduce Risk of Pressure Ulcers
El Camino Hospital, a leader in the use of technology to improve patient care, is utilizing the Leaf Patient Monitoring system to help prevent hospital-acquired pressure ulcers by monitoring the position and movement of...More >>
El Camino Hospital, a leader in the use of technology to improve patient care, is utilizing the Leaf Patient Monitoring system to help prevent hospital-acquired pressure ulcers by monitoring the position and movement of...More >>
Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant
Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant
A study presented at the 2014 World Transplant Congress evaluated the safety and efficacy of CSL Behring's C1 Inhibitor (C1-INH) concentrate in preventing antibody-mediated rejection following kidney transplants in...More >>
A study presented at the 2014 World Transplant Congress evaluated the safety and efficacy of CSL Behring's C1 Inhibitor (C1-INH) concentrate in preventing antibody-mediated rejection following kidney transplants in...More >>
Ascension Forms New National Senior Care Health Ministry
Ascension Forms New National Senior Care Health Ministry
Ascension, the nation's largest Catholic and non-profit health system, today announced the formation of Ascension Health Senior Care, uniting the majority of its senior-focused programs into one national organization.More >>
Ascension, the nation's largest Catholic and non-profit health system, today announced the formation of Ascension Health Senior Care, uniting the majority of its senior-focused programs into one national organization.More >>
Biggest Loser finalist Joe Ostaszewski to bike across America inspiring national fight against obesity
Biggest Loser finalist Joe Ostaszewski to bike across America inspiring national fight against obesity
Joe Ostaszewski, Biggest Loser finalist and former Florida State University defensive lineman, says the Biggest Loser show saved his life. Now, he's "riding it forward" in a 2,900-mile bike ride across the country to...More >>
Joe Ostaszewski, Biggest Loser finalist and former Florida State University defensive lineman, says the Biggest Loser show saved his life. Now, he's "riding it forward" in a 2,900-mile bike ride across the country to...More >>
Growing Popularity of Multimodality Imaging Will Drive the Preclinical Animal Research Imaging System Market
Growing Popularity of Multimodality Imaging Will Drive the Preclinical Animal Research Imaging System Market
Decision Resources Group finds that the United States preclinical animal research imaging system market will be significantly driven by the trend toward multimodality imaging, such as combining computed tomography and...More >>
Decision Resources Group finds that the United States preclinical animal research imaging system market will be significantly driven by the trend toward multimodality imaging, such as combining computed tomography and...More >>
mHealth and Home Monitoring - 6th Edition
mHealth and Home Monitoring - 6th Edition
Reportlinker.com announces that a new market research report is available in its catalogue: mHealth and Home Monitoring – 6th Edition http://www.reportlinker.com/p0356852/mHealth-and-Home-Monitoring-–-6th-Edition.htmlMore >>
Reportlinker.com announces that a new market research report is available in its catalogue: mHealth and Home Monitoring – 6th Edition http://www.reportlinker.com/p0356852/mHealth-and-Home-Monitoring-–-6th-Edition.htmlMore >>
Global and Chinese Aseptic Packaging Industry Report 2014
Global and Chinese Aseptic Packaging Industry Report 2014
Research and Markets has announced the addition of the "Global and Chinese Aseptic Packaging Industry Report 2014" report to their offering.More >>
Research and Markets has announced the addition of the "Global and Chinese Aseptic Packaging Industry Report 2014" report to their offering.More >>
Ebola Virus Gene Replikin Count Increased Sixteen-fold in 2013 in Advance of Current Outbreaks
Ebola Virus Gene Replikin Count Increased Sixteen-fold in 2013 in Advance of Current Outbreaks
Replikins Ltd. today released new data on changes in the gene structure of the Ebola virus. Before the current outbreaks, the mean Ebola Reston gene Replikin Count (number of Replikins per 100 amino acids) between 1995 and...More >>
Replikins Ltd. today released new data on changes in the gene structure of the Ebola virus. Before the current outbreaks, the mean Ebola Reston gene Replikin Count (number of Replikins per 100 amino acids) between 1995 and...More >>
InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada
InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada
InnoPharma, Inc. today announced the first generic launch of Olanzapine for Injection, 10mg/vial (the generic equivalent of Zyprexa® injection), in Canada. Olanzapine is indicated for the rapid control of agitation and...More >>
InnoPharma, Inc. today announced the first generic launch of Olanzapine for Injection, 10mg/vial (the generic equivalent of Zyprexa® injection), in Canada. Olanzapine is indicated for the rapid control of agitation and...More >>
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Galectin Therapeutics, Inc.
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Galectin Therapeutics, Inc.
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Galectin Therapeutics, Inc. ("Galectin Therapeutics" or the "Company")...More >>
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Galectin Therapeutics, Inc. ("Galectin Therapeutics" or the "Company")...More >>
The U.S. Clot Management Device Market Will Experience Accelerating Growth, Reaching Revenues of $700 Million in 2022
The U.S. Clot Management Device Market Will Experience Accelerating Growth, Reaching Revenues of $700 Million in 2022
Decision Resources Group finds that the United States clot management device market will expand through 2022, particularly in the later years. This will be primarily as a result of increasing uptake of neurovascular...More >>
Decision Resources Group finds that the United States clot management device market will expand through 2022, particularly in the later years. This will be primarily as a result of increasing uptake of neurovascular...More >>
Former Marine and Self-Described 'Proud Mexican American' Finally Finds His Way to Career of His Dreams
Former Marine and Self-Described 'Proud Mexican American' Finally Finds His Way to Career of His Dreams
Pharmacy is not Antonio Silva's first career, but he is certain it will be his last. In the past, the 34-year-old Riverside, California, resident has served in the U.S. Marine Corps and owned and operated his own small...More >>
Pharmacy is not Antonio Silva's first career, but he is certain it will be his last. In the past, the 34-year-old Riverside, California, resident has served in the U.S. Marine Corps and owned and operated his own small...More >>
Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation
Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation
Unique Pizza and Subs Corporation ("Unique," OTC Markets Groups Inc.: OTC Pink: UPZS), a Delaware Corporation, is pleased to announce it has signed a distribution agreement with Larasan Pharmaceutical Corporation...More >>
Unique Pizza and Subs Corporation ("Unique," OTC Markets Groups Inc.: OTC Pink: UPZS), a Delaware Corporation, is pleased to announce it has signed a distribution agreement with Larasan Pharmaceutical Corporation...More >>
Valeant Awards Winners of Second Annual I Acanya® Succeed Scholarship Program $48,000 Each Toward College Tuition
Valeant Awards Winners of Second Annual I Acanya® Succeed Scholarship Program $48,000 Each Toward College Tuition
Valeant Pharmaceuticals North America LLC, today announced the 2014 winners of the Second annual I Acanya® Succeed scholarship program, an education-based initiative that rewards college students for taking a proactive...More >>
Valeant Pharmaceuticals North America LLC, today announced the 2014 winners of the Second annual I Acanya® Succeed scholarship program, an education-based initiative that rewards college students for taking a proactive...More >>
DigiPath No New Corporate Developments
DigiPath No New Corporate Developments
DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is expanding into the cannabis testing and education markets, announced today that has been no material development in its business and...More >>
DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is expanding into the cannabis testing and education markets, announced today that has been no material development in its business and...More >>
Dr. Duke Fu Announced as New President of Premiere Marijuana Consulting and Management Firm The MedMen
Dr. Duke Fu Announced as New President of Premiere Marijuana Consulting and Management Firm The MedMen
The MedMen, the first and leading consulting and management firm in the marijuana industry, is proud to announce the appointment of Dr. Duke Fu as President of the company after leaving behind five years of indispensable...More >>
The MedMen, the first and leading consulting and management firm in the marijuana industry, is proud to announce the appointment of Dr. Duke Fu as President of the company after leaving behind five years of indispensable...More >>
UMD Researchers Bridge Gap between Microelectronics, Biological Systems
UMD Researchers Bridge Gap between Microelectronics, Biological Systems
Researchers often use microelectronic devices embedded with biological components to interrogate biology, but such devices can do much more – perhaps even control biology.More >>
Researchers often use microelectronic devices embedded with biological components to interrogate biology, but such devices can do much more – perhaps even control biology.More >>
Janssen Pharmaceuticals, Inc. Announced As NASCAR Sprint Cup Series™ Event Entitlement Partner At Chicagoland Speedway
Janssen Pharmaceuticals, Inc. Announced As NASCAR Sprint Cup Series™ Event Entitlement Partner At Chicagoland Speedway
Chicagoland Speedway today announced Janssen Pharmaceuticals, Inc., the official cardiovascular partner of NASCAR®, as the title sponsor of this year's first Chase for the NASCAR Sprint Cup™ race. The MyAFibStory.com...More >>
Chicagoland Speedway today announced Janssen Pharmaceuticals, Inc., the official cardiovascular partner of NASCAR®, as the title sponsor of this year's first Chase for the NASCAR Sprint Cup™ race. The MyAFibStory.com...More >>
Access Pharmaceuticals Featured On OncLive.com
Access Pharmaceuticals Featured On OncLive.com
ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a developer of new products for oncology supportive care, announced that its novel product for oral mucositis, MuGard®, has been featured in an article on OncLive.com titled,...More >>
ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a developer of new products for oncology supportive care, announced that its novel product for oral mucositis, MuGard®, has been featured in an article on OncLive.com titled,...More >>
Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation
Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation
Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a biopharmaceutical company developing addiction treatments based on its expertise in opioid antagonists, announced today that it has received a funding commitment...More >>
Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a biopharmaceutical company developing addiction treatments based on its expertise in opioid antagonists, announced today that it has received a funding commitment...More >>
Cynosure Appoints Chief Operating Officer and Chief Financial Officer Timothy W. Baker as President
Cynosure Appoints Chief Operating Officer and Chief Financial Officer Timothy W. Baker as President
Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based aesthetic treatments for non-invasive and minimally invasive applications, today announced that the Board of Directors has promoted Executive Vice...More >>
Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based aesthetic treatments for non-invasive and minimally invasive applications, today announced that the Board of Directors has promoted Executive Vice...More >>
Managed Health Care Stocks Technical Review -- WellCare Health Plans, Aetna, Centene, WellPoint, and Molina Healthcare
Managed Health Care Stocks Technical Review -- WellCare Health Plans, Aetna, Centene, WellPoint, and Molina Healthcare
On Tuesday, July 29, 2014, the NASDAQ Composite ended at 4,442.70, down 0.05%, the Dow Jones Industrial Average finished the day 0.42% lower at 16,912.11, and the S&P 500 closed at 1,969.95, down 0.45%. The losses were...More >>
On Tuesday, July 29, 2014, the NASDAQ Composite ended at 4,442.70, down 0.05%, the Dow Jones Industrial Average finished the day 0.42% lower at 16,912.11, and the S&P 500 closed at 1,969.95, down 0.45%. The losses were...More >>
Skyline Urology Chief Medical Officer Dr. Richard David Named Professor Of Urology At UCLA
Skyline Urology Chief Medical Officer Dr. Richard David Named Professor Of Urology At UCLA
Skyline Urology Chief Medical Officer Dr. Richard David has been named Clinical Professor of Urology, Voluntary at the David Geffen School of Medicine at UCLA.More >>
Skyline Urology Chief Medical Officer Dr. Richard David has been named Clinical Professor of Urology, Voluntary at the David Geffen School of Medicine at UCLA.More >>
invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors
invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors
invendo medical GmbH, manufacturer and distributor of a single use and computer-assisted ("robotic") colonoscopy system, today announced the appointment of Nachum (Homi) Shamir, a worldwide recognized medical device...More >>
invendo medical GmbH, manufacturer and distributor of a single use and computer-assisted ("robotic") colonoscopy system, today announced the appointment of Nachum (Homi) Shamir, a worldwide recognized medical device...More >>
PCI Announces Definitive Agreement to Acquire Penn Pharma
PCI Announces Definitive Agreement to Acquire Penn Pharma
Packaging Coordinators, Inc. (PCI) is pleased to announce it has reached a definitive agreement to acquire Penn Pharmaceutical Services Limited (Penn Pharma). Penn Pharma is headquartered in Tredegar, Wales in the United...More >>
Packaging Coordinators, Inc. (PCI) is pleased to announce it has reached a definitive agreement to acquire Penn Pharmaceutical Services Limited (Penn Pharma). Penn Pharma is headquartered in Tredegar, Wales in the United...More >>
Global Retinal Vein Occlusion Market 2014-2018: Key Vendors are Bayer, F. Hoffmann-La Roche, Novartis and Regeneron Pharmaceuticals
Global Retinal Vein Occlusion Market 2014-2018: Key Vendors are Bayer, F. Hoffmann-La Roche, Novartis and Regeneron Pharmaceuticals
Research and Markets has announced the addition of the "Global Retinal Vein Occlusion Market 2014-2018" report to their offering.More >>
Research and Markets has announced the addition of the "Global Retinal Vein Occlusion Market 2014-2018" report to their offering.More >>
New Vitamin D Research: Supplementation Is Best Way To Improve Vitamin D Levels
New Vitamin D Research: Supplementation Is Best Way To Improve Vitamin D Levels
Do you currently take a vitamin D supplement? New research says you should. A study conducted by USANA Health Sciences, in conjunction with Intermountain Healthcare's The Orthopedic Specialty Hospital (TOSH), found...More >>
Do you currently take a vitamin D supplement? New research says you should. A study conducted by USANA Health Sciences, in conjunction with Intermountain Healthcare's The Orthopedic Specialty Hospital (TOSH), found...More >>
Perrigo Confirms First To File Patent Challenge For Generic Version Of Topicort® Topical Spray 0.25%
Perrigo Confirms First To File Patent Challenge For Generic Version Of Topicort® Topical Spray 0.25%
Perrigo Company (NYSE: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application for desoximetasone topical spray 0.25% and that it has notified Taro...More >>
Perrigo Company (NYSE: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application for desoximetasone topical spray 0.25% and that it has notified Taro...More >>
Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship
Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship
Stryker brand ambassadors Fred Funk and Hal Sutton are playing this week at the 3M Championship Champions Tour event near Minneapolis, MN, which begins Friday at TPC Twin Cities, in Blaine. Stryker is the official joint...More >>
Stryker brand ambassadors Fred Funk and Hal Sutton are playing this week at the 3M Championship Champions Tour event near Minneapolis, MN, which begins Friday at TPC Twin Cities, in Blaine. Stryker is the official joint...More >>
Report: Biopharma and Medical Device Companies Beat Historic Investment Returns
Report: Biopharma and Medical Device Companies Beat Historic Investment Returns
Silicon Valley Bank, the bank of the global innovation economy, released a study today that examines the merger, acquisition and IPO activity of private, venture-backed biopharma and medical device companies. According to...More >>
Silicon Valley Bank, the bank of the global innovation economy, released a study today that examines the merger, acquisition and IPO activity of private, venture-backed biopharma and medical device companies. According to...More >>
Study Shows that RapidArc® Radiosurgery Substantially More Efficient and Comparable in Quality to Gamma Knife® in the Treatment of Multiple Brain Metastases
Study Shows that RapidArc® Radiosurgery Substantially More Efficient and Comparable in Quality to Gamma Knife® in the Treatment of Multiple Brain Metastases
RapidArc® Radiosurgery can be used to deliver treatments for multiple brain metastases that are substantially less time consuming and comparable in quality to Gamma Knife® (GK) treatments, according to a new research study...More >>
RapidArc® Radiosurgery can be used to deliver treatments for multiple brain metastases that are substantially less time consuming and comparable in quality to Gamma Knife® (GK) treatments, according to a new research study...More >>
Take Shape For Life Launches Habits of Healthy Sleep Set
Take Shape For Life Launches Habits of Healthy Sleep Set
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss products and programs, is proud to announce a new line of products available in its Take Shape For Life...More >>
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss products and programs, is proud to announce a new line of products available in its Take Shape For Life...More >>
Entinostat Improves Treatment Outcomes When Combined with Immune Checkpoint Blockade in Preclinical Tumor Models
Entinostat Improves Treatment Outcomes When Combined with Immune Checkpoint Blockade in Preclinical Tumor Models
Syndax Pharmaceuticals, Inc. today announced that newly published results demonstrate that in preclinical studies entinostat significantly improved treatment outcomes in mouse tumor models when combined with anti-PD1 and...More >>
Syndax Pharmaceuticals, Inc. today announced that newly published results demonstrate that in preclinical studies entinostat significantly improved treatment outcomes in mouse tumor models when combined with anti-PD1 and...More >>
PTC Therapeutics to Present at the Wedbush Life Sciences Management Access Conference
PTC Therapeutics to Present at the Wedbush Life Sciences Management Access Conference
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company update at the Wedbush Life Sciences Management Access Conference on Tuesday, August 12th at 4:15 pm ET at the Le Parker Meridien...More >>
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company update at the Wedbush Life Sciences Management Access Conference on Tuesday, August 12th at 4:15 pm ET at the Le Parker Meridien...More >>
Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia
Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that nine new Phase 3 ODYSSEY trials of alirocumab in people with hypercholesterolemia met their primary efficacy...More >>
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that nine new Phase 3 ODYSSEY trials of alirocumab in people with hypercholesterolemia met their primary efficacy...More >>
Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia
Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia
Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that nine new Phase 3 ODYSSEY trials of alirocumab in people with hypercholesterolemia met their primary efficacy...More >>
Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that nine new Phase 3 ODYSSEY trials of alirocumab in people with hypercholesterolemia met their primary efficacy...More >>
GenSpera Announces US Patent for Methods and Compositions for the Detection, Imaging and Treatment of Cancer
GenSpera Announces US Patent for Methods and Compositions for the Detection, Imaging and Treatment of Cancer
GenSpera, Inc. (OTCQB: GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, announces the issuance of a United States patent entitled "Methods and compositions for the detection of cancer". The...More >>
GenSpera, Inc. (OTCQB: GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, announces the issuance of a United States patent entitled "Methods and compositions for the detection of cancer". The...More >>
Ampio Pharmaceuticals announces the FDA has issued a written response and accepted the Ampio plan for beginning production of Ampion™ in the new facility.
Ampio Pharmaceuticals announces the FDA has issued a written response and accepted the Ampio plan for beginning production of Ampion™ in the new facility.
Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced a positive written response from the FDA in regards to the company's plans to begin production of AmpionTM in our new drug manufacturing facility.More >>
Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced a positive written response from the FDA in regards to the company's plans to begin production of AmpionTM in our new drug manufacturing facility.More >>
Orexigen Receives CHMP Day 180 List of Outstanding Issues
Orexigen Receives CHMP Day 180 List of Outstanding Issues
Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced it has received the Day 180 List of Outstanding Issues (LOI) from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for the...More >>
Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced it has received the Day 180 List of Outstanding Issues (LOI) from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for the...More >>
Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity
Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity
Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that an article based on post-hoc analyses from the three pivotal Phase 3 trials of lorcaserin entitled, "Early Weight Loss While on Lorcaserin,...More >>
Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that an article based on post-hoc analyses from the three pivotal Phase 3 trials of lorcaserin entitled, "Early Weight Loss While on Lorcaserin,...More >>
Adeptus Health Reports Second Quarter Results
Adeptus Health Reports Second Quarter Results
Adeptus Health Inc. (NYSE: ADPT) ("ADPT" or the "Company") announced its results for the second quarter ended June 30, 2014. All comparisons included in this release are for the second quarter 2014 to the second quarter...More >>
Adeptus Health Inc. (NYSE: ADPT) ("ADPT" or the "Company") announced its results for the second quarter ended June 30, 2014. All comparisons included in this release are for the second quarter 2014 to the second quarter...More >>
Hospira Reports Second-Quarter 2014 Results
Hospira Reports Second-Quarter 2014 Results
Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today reported results for the second quarter ended June 30, 2014. Net sales for the quarter were $1.1 billion and...More >>
Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today reported results for the second quarter ended June 30, 2014. Net sales for the quarter were $1.1 billion and...More >>
A Shot of Good Health – CRY India's Immunization Campaign
A Shot of Good Health – CRY India's Immunization Campaign
Gopika was born against all the odds in an area of India where foeticide is prevalent. Hailing from Ponamalai Nagar, a village in the Salem district of Andhra Pradesh, her family cherished their daughter, taking the utmost...More >>
Gopika was born against all the odds in an area of India where foeticide is prevalent. Hailing from Ponamalai Nagar, a village in the Salem district of Andhra Pradesh, her family cherished their daughter, taking the utmost...More >>
Covance Inc. Invites You to Join the Webcast of Its Second Quarter 2014 Financial Results Conference Call
Covance Inc. Invites You to Join the Webcast of Its Second Quarter 2014 Financial Results Conference Call
In conjunction with its second quarter 2014 earnings release (expected to be issued after market close on July 29, 2014), Covance Inc. (NYSE: CVD) is pleased to invite you to listen to its quarterly investor conference...More >>
In conjunction with its second quarter 2014 earnings release (expected to be issued after market close on July 29, 2014), Covance Inc. (NYSE: CVD) is pleased to invite you to listen to its quarterly investor conference...More >>
Bluegrass Vascular Technologies Raises $4.5M Series A Financing Led By Targeted Technology Funds
Bluegrass Vascular Technologies Raises $4.5M Series A Financing Led By Targeted Technology Funds
Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access, today announced it has closed $4.5 million in Series A financing, which was...More >>
Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access, today announced it has closed $4.5 million in Series A financing, which was...More >>
RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars
RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars
RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies,...More >>
RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies,...More >>
PDL BioPharma to Participate in Jefferies 2014 Boston Healthcare Summit
PDL BioPharma to Participate in Jefferies 2014 Boston Healthcare Summit
PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that company management will participate in the Jefferies 2014 Boston Healthcare Summit next week in Boston, Massachusetts. The conference will occur on August 6,...More >>
PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that company management will participate in the Jefferies 2014 Boston Healthcare Summit next week in Boston, Massachusetts. The conference will occur on August 6,...More >>
AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001
AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001
AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces that its partner,...More >>
AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces that its partner,...More >>
T.J. Martell Foundation Announces Honorees for 39th New York Honors Gala
T.J. Martell Foundation Announces Honorees for 39th New York Honors Gala
The T.J. Martell Foundation for Leukemia, Cancer and AIDS Research has announced the honorees for its 39th Annual Honors Gala on Tuesday, October 21, 2014 which will be held at the legendary Cipriani in New York. The...More >>
The T.J. Martell Foundation for Leukemia, Cancer and AIDS Research has announced the honorees for its 39th Annual Honors Gala on Tuesday, October 21, 2014 which will be held at the legendary Cipriani in New York. The...More >>
Medical Equipment Solutions Corp. Awarded $2 Million contract To Service DoD
Medical Equipment Solutions Corp. Awarded $2 Million contract To Service DoD
Medical Equipment Solutions, Corp. are pleased to announce that they have been awarded a Department of Defense (US Army) contract valued at over $2 million over 30 months to supply a mobile MRI diagnostic machine and...More >>
Medical Equipment Solutions, Corp. are pleased to announce that they have been awarded a Department of Defense (US Army) contract valued at over $2 million over 30 months to supply a mobile MRI diagnostic machine and...More >>
Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine
Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine
Epic Sciences, Inc. ("Epic"), a privately held biotech company that designs and develops novel diagnostics to personalize and advance the treatment and management of cancer, announced today the completion of a $30 million...More >>
Epic Sciences, Inc. ("Epic"), a privately held biotech company that designs and develops novel diagnostics to personalize and advance the treatment and management of cancer, announced today the completion of a $30 million...More >>
Epic Sciences Appoints Greg Lucier as Chairman of the Board of Directors
Epic Sciences Appoints Greg Lucier as Chairman of the Board of Directors
Epic Sciences, Inc. ("Epic"), a private biotech company that designs and develops novel diagnostics to personalize and advance the treatment and management of cancer, announced today the appoint of Gregory T. Lucier as...More >>
Epic Sciences, Inc. ("Epic"), a private biotech company that designs and develops novel diagnostics to personalize and advance the treatment and management of cancer, announced today the appoint of Gregory T. Lucier as...More >>
Intouch Solutions Launches SocialQueue™, A Real-Time Social Monitoring Tool For Pharma
Intouch Solutions Launches SocialQueue™, A Real-Time Social Monitoring Tool For Pharma
Intouch Solutions®, a marketing agency servicing the pharmaceutical industry, announced the availability of SocialQueue. SocialQueue gives pharma companies a new tool to easily monitor and manage activity across their...More >>
Intouch Solutions®, a marketing agency servicing the pharmaceutical industry, announced the availability of SocialQueue. SocialQueue gives pharma companies a new tool to easily monitor and manage activity across their...More >>
eInfochips to Develop NVIDIA GPU-powered Solutions for Aerospace and Defense, Medical Imaging, HPC and Visual Computing
eInfochips to Develop NVIDIA GPU-powered Solutions for Aerospace and Defense, Medical Imaging, HPC and Visual Computing
Company expands reach of latest GPU technology and CUDA programming expertise to big data, aerospace and defense, medical, and industrial, among other markets eInfochips, a leading engineering R&D services company,...More >>
Company expands reach of latest GPU technology and CUDA programming expertise to big data, aerospace and defense, medical, and industrial, among other markets eInfochips, a leading engineering R&D services company,...More >>
Immune Pharmaceuticals Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin
Immune Pharmaceuticals Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin
Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX First North Premier, Stockholm: "IMNP."; "Immune" or "the Company") announces today that it has initiated the screening of patients for a Phase II proof of concept clinical...More >>
Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX First North Premier, Stockholm: "IMNP."; "Immune" or "the Company") announces today that it has initiated the screening of patients for a Phase II proof of concept clinical...More >>
EDG Partners Invests in MMIS
EDG Partners Invests in MMIS
EDG Partners today announced a growth equity investment in MMIS, Inc. (MMIS), a global technology company that develops and markets compliance and collaboration software solutions for pharmaceutical and medical device...More >>
EDG Partners today announced a growth equity investment in MMIS, Inc. (MMIS), a global technology company that develops and markets compliance and collaboration software solutions for pharmaceutical and medical device...More >>
EYLEA® (aflibercept) Injection Receives FDA Approval for the Treatment of Diabetic Macular Edema (DME)
EYLEA® (aflibercept) Injection Receives FDA Approval for the Treatment of Diabetic Macular Edema (DME)
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has approved EYLEA® (aflibercept) Injection for the treatment of Diabetic Macular Edema (DME). The...More >>
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has approved EYLEA® (aflibercept) Injection for the treatment of Diabetic Macular Edema (DME). The...More >>
Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37
Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37
Amgen (NASDAQ: AMGN) today announced financial results for the second quarter of 2014. Key results include:More >>
Amgen (NASDAQ: AMGN) today announced financial results for the second quarter of 2014. Key results include:More >>
Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point
Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point
Express Scripts Holding Company (Nasdaq: ESRX) announced 2014 second quarter net income attributable to Express Scripts stockholders of $515.2 million, or $0.67 per diluted share. Adjusted earnings per diluted share, as...More >>
Express Scripts Holding Company (Nasdaq: ESRX) announced 2014 second quarter net income attributable to Express Scripts stockholders of $515.2 million, or $0.67 per diluted share. Adjusted earnings per diluted share, as...More >>
Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences
Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that it is participating in two healthcare conferences during the third quarter, the 2014 Avondale Partners Healthcare 1-1 Conference and the Morgan Stanley...More >>
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that it is participating in two healthcare conferences during the third quarter, the 2014 Avondale Partners Healthcare 1-1 Conference and the Morgan Stanley...More >>
Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million
Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million
Covance Inc. (NYSE: CVD) today reported results for its second quarter ended June 30, 2014. Net revenue was $639 million, representing 8.0% growth from the second quarter of 2013. On a GAAP basis, the company reported...More >>
Covance Inc. (NYSE: CVD) today reported results for its second quarter ended June 30, 2014. Net revenue was $639 million, representing 8.0% growth from the second quarter of 2013. On a GAAP basis, the company reported...More >>
Regado Biosciences to Provide Second Quarter 2014 Financial Results and Corporate Highlights
Regado Biosciences to Provide Second Quarter 2014 Financial Results and Corporate Highlights
Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the Phase 3 clinical development of Revolixys™ Kit (previously known as REG1), its first-in-class, actively controllable antithrombotic drug...More >>
Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the Phase 3 clinical development of Revolixys™ Kit (previously known as REG1), its first-in-class, actively controllable antithrombotic drug...More >>
Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014
Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today reported total revenues of $39.8 million for the second quarter of 2014, an increase of 62% compared to revenues...More >>
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today reported total revenues of $39.8 million for the second quarter of 2014, an increase of 62% compared to revenues...More >>
Sequenom Enters Into License Agreement With Mayo Medical Laboratories
Sequenom Enters Into License Agreement With Mayo Medical Laboratories
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company that provides innovative genetic analysis solutions, and Mayo Medical Laboratories (MML), the third-largest provider of esoteric laboratory services in the United...More >>
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company that provides innovative genetic analysis solutions, and Mayo Medical Laboratories (MML), the third-largest provider of esoteric laboratory services in the United...More >>
Pfenex Announces Closing of Initial Public Offering
Pfenex Announces Closing of Initial Public Offering
Pfenex Inc. (NYSE MKT: PFNX) today announced that it has closed its previously announced initial public offering of 8,333,333 shares of its common stock at a price to the public of $6.00 per share. All of the common stock...More >>
Pfenex Inc. (NYSE MKT: PFNX) today announced that it has closed its previously announced initial public offering of 8,333,333 shares of its common stock at a price to the public of $6.00 per share. All of the common stock...More >>
Team Health Holdings, Inc. Announces Second Quarter 2014 Financial Results
Team Health Holdings, Inc. Announces Second Quarter 2014 Financial Results
Landauer, Inc. Sets Date and Time for Announcement of Fiscal Third Quarter 2014 Results
Landauer, Inc. Sets Date and Time for Announcement of Fiscal Third Quarter 2014 Results
Landauer, Inc. (NYSE: LDR), a recognized leader in personal and environmental radiation measurement and monitoring, outsourced medical physics services and high quality medical consumable accessories, will release...More >>
Landauer, Inc. (NYSE: LDR), a recognized leader in personal and environmental radiation measurement and monitoring, outsourced medical physics services and high quality medical consumable accessories, will release...More >>
IMRIS to hold second quarter 2014 results conference call
IMRIS to hold second quarter 2014 results conference call
WINNIPEG, MB and MIINNEAPOLIS, MN, July 29, 2014 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM)More >>
WINNIPEG, MB and MIINNEAPOLIS, MN, July 29, 2014 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM)More >>
ImmunoCellular Therapeutics to Report Financial Results for the Second Quarter 2014 on August 7, 2014
ImmunoCellular Therapeutics to Report Financial Results for the Second Quarter 2014 on August 7, 2014
ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced that it plans to report second quarter 2014 financial results on Thursday, August 7, 2014. ImmunoCellular will host a conference call...More >>
ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced that it plans to report second quarter 2014 financial results on Thursday, August 7, 2014. ImmunoCellular will host a conference call...More >>
Edwards Lifesciences Reports Strong Second Quarter Results
Edwards Lifesciences Reports Strong Second Quarter Results
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today reported net income for the quarter ended June 30, 2014 of $547.0 million, or $5.09 per...More >>
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today reported net income for the quarter ended June 30, 2014 of $547.0 million, or $5.09 per...More >>
EnteroMedics to Host Second Quarter 2014 Financial Results and Business Update Conference Call
EnteroMedics to Host Second Quarter 2014 Financial Results and Business Update Conference Call
EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that it will host a conference...More >>
EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that it will host a conference...More >>
Franz Och, Ph.D., Expert in Machine Learning and Machine Translation, Joins Human Longevity, Inc. as Chief Data Scientist
Franz Och, Ph.D., Expert in Machine Learning and Machine Translation, Joins Human Longevity, Inc. as Chief Data Scientist
Human Longevity, Inc. (HLI), a genomics and cell therapy-based diagnostic and therapeutic company focused on extending the healthy, high performance human life span, today announced they have hired Franz Och, Ph.D., an...More >>
Human Longevity, Inc. (HLI), a genomics and cell therapy-based diagnostic and therapeutic company focused on extending the healthy, high performance human life span, today announced they have hired Franz Och, Ph.D., an...More >>

PR Newswire IndexMore>>
Entertainment News Releases via PRNewswire
Entertainment
Entertainment News Releases via PRNewswire
Travel
Travel News Releases via PRNewswire
Political Campaigns
Political Campaigns News Releases via PRNewswire
Medicine & Pharmaceuticals
Medicine & Pharmaceuticals News Releases via PRNewswire
Film & Motion Picture News Releases via PRNewswire
Film & Motion Picture
Film & Motion Picture News Releases via PRNewswire
Economic News and Analysis
Economic News Releases via PRNewswire
Computer Software
Computer Software News Releases via PRNewswire
Computer Networks
Computer Networks News Releases via PRNewswire
Computer Hardware
Computer Hardware News Releases via PRNewswire
Biotech News Releases via PRNewswire
Biotechnology
Biotechnology News Releases via PRNewswire

ABC6 ExtraMore>>
Big Deal
Big Deal
Click here to get 1/2 off gift certificates!More >>
Get Half-Priced Gift Certificates!More >>
Contests
Contests
Click here to see our ABC6 Contests page!More >>
Click here to see our ABC6 Contests page!More >>
Lottery
Lottery
Is today your lucky day? Click here to get the daily numbers.More >>
Horoscopes
Horoscopes
Daily horoscopes for life, love, work and more!More >>
Green Living
Green Living
Find latest environmental news, tips and information for staying green.More >>
Pets
Pets
Learn more tips for caring for, grooming and training your favorite pet.More >>

Medicine & Pharmaceuticals - ABC6 - Providence, RI and New Bedford, MA News, Weather

HeadlinesMore>>